Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antibiotic Prophylaxis When Removing Ureteric Stent After Stone Surgery

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Tor Erik Sand, Akershus University College.
Recruitment status was:  Not yet recruiting
Information provided by (Responsible Party):
Tor Erik Sand, Akershus University College Identifier:
First received: January 14, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
Is there anything to gain in giving antibiotics as prophylaxis when removing ureteric stents cystoscopically after stone surgery?

Condition Intervention
Ureteric Stent After Stone Surgery
Drug: Trimetoprim-Sulfa (Bactrim)
Other: No antibiotics

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:

Further study details as provided by Tor Erik Sand, Akershus University College:

Primary Outcome Measures:
  • 14 days infection rate w/wo antibiotics [ Time Frame: 14 days ]

Secondary Outcome Measures:
  • infection rate with ureter stent wo antibiotics [ Time Frame: 14 days ]

Estimated Enrollment: 124
Study Start Date: January 2013
Estimated Study Completion Date: April 2016
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Antibiotics
will receive antibiotics
Drug: Trimetoprim-Sulfa (Bactrim)
Active Comparator: No antibiotics
will not receive antibiotics
Other: No antibiotics

Detailed Description:
Many patients undergoing stone surgery receive a ureteric stent that should be removed after 14 days. This stent is removed cystoscopically and today this is done without giving antibiotics. Some patients get urinary tract infections subject to this. However the investigators do not know how many of these patients get UTI as most are followed by their primary care doctor. With this study the investigators would like to find out whether it is possible to avoid such infections and also find out how many actually do get infected.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • stone surgery patients with ureteric stent that should be removed after 14 days

Exclusion Criteria:

  • ongoing antibiotic treatment, allergy to trimetoprim-sulfa
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01768364

Contact: Tor Erik Sand, MD, PhD
Contact: Manuela Estop-Garanto, MD

Akershus University Hospital Not yet recruiting
Lorenskog, Norway, 1478
Contact: Manuela Estop-Garanto, MD   
Contact: Tor Erik Sand, MD, PhD   
Principal Investigator: Tor Erik Sand, MD, PhD         
Sponsors and Collaborators
Tor Erik Sand
Principal Investigator: Tor Erik Sand, MD. PhD University Hospital, Akershus
  More Information

Responsible Party: Tor Erik Sand, Professor, M.D., Ph.D., Akershus University College Identifier: NCT01768364     History of Changes
Other Study ID Numbers: 2012/953
Study First Received: January 14, 2013
Last Updated: January 14, 2013

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antitubercular Agents processed this record on May 25, 2017